171 related articles for article (PubMed ID: 34631264)
21. Excess body weight and increased Breslow thickness in melanoma patients: a retrospective study.
de Giorgi V; Gori A; Papi F; Grazzini M; Rossari S; Verdelli A; Crocetti E; Savarese I; Giorgi L; Massi D
Eur J Cancer Prev; 2013 Sep; 22(5):480-5. PubMed ID: 23462459
[TBL] [Abstract][Full Text] [Related]
22. Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick.
Gould Rothberg BE; Bulloch KJ; Fine JA; Barnhill RL; Berwick M
Cancer Epidemiol; 2014 Oct; 38(5):599-607. PubMed ID: 25194935
[TBL] [Abstract][Full Text] [Related]
23. Obesity in breast cancer--what is the risk factor?
James FR; Wootton S; Jackson A; Wiseman M; Copson ER; Cutress RI
Eur J Cancer; 2015 Apr; 51(6):705-20. PubMed ID: 25747851
[TBL] [Abstract][Full Text] [Related]
24. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
[TBL] [Abstract][Full Text] [Related]
25. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
26. Bariatric surgery: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(1):1-148. PubMed ID: 23074460
[TBL] [Abstract][Full Text] [Related]
27. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
Tanvig M
Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
[TBL] [Abstract][Full Text] [Related]
29. BILLCD8 - A Multivariable Survival Model as a Simple and Clinically Useful Prognostic Tool to Identify High-risk Cutaneous Melanoma Patients.
Donizy P; Biecek P; Halon A; Matkowski R
Anticancer Res; 2016 Sep; 36(9):4739-47. PubMed ID: 27630321
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic Features of Cutaneous Malignant Melanoma and Their Impact on Prognosis.
Atique U; Mushtaq S; Rana IA; Hassan U
Cureus; 2020 Sep; 12(9):e10450. PubMed ID: 33072458
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
32. The influence of body mass index on the survival of patients with melanoma. A cross-sectional study of 707 patients.
Zepeda-Najar C; Lino-Silva LS; Chávez-Hernandez JD; Salcedo-Hernández RA; Jimenez-Sánchez JP; Fernández-Sánchez CE; Valdez-Aguilar CD
Contemp Oncol (Pozn); 2021; 25(1):23-27. PubMed ID: 33911978
[TBL] [Abstract][Full Text] [Related]
33. Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma.
Chu MP; Li Y; Ghosh S; Sass S; Smylie M; Walker J; Sawyer MB
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):748-755. PubMed ID: 32053287
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Obesity on Surgically Treated Locoregional Melanoma.
Harrell Shreckengost CS; Tariq M; Farley CR; Zhang C; Delman KA; Kudchadkar RR; Lowe MC
Ann Surg Oncol; 2021 Oct; 28(11):6140-6151. PubMed ID: 33718977
[TBL] [Abstract][Full Text] [Related]
35. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
36. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
Ara R; Blake L; Gray L; Hernández M; Crowther M; Dunkley A; Warren F; Jackson R; Rees A; Stevenson M; Abrams K; Cooper N; Davies M; Khunti K; Sutton A
Health Technol Assess; 2012; 16(5):iii-xiv, 1-195. PubMed ID: 22340890
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
38. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
39. Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
Smith LK; Arabi S; Lelliott EJ; McArthur GA; Sheppard KE
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549336
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
